Kraig Biocraft Laboratories' Monster Silk(TM) Cocoons Now Being Reeled
March 19 2013 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the "Company" or
"Kraig"), the leading developer of advanced spider silk based
fibers, announced today that the cocoons from the first stage of
its Monster Silk™ pilot production program ("program") have been
reeled into threads of the Company's recombinant spider silk as the
program moves into an advanced state.
Additionally, the silkworm hatchlings from the second stage of
the program have now spun cocoons that are made of Monster
Silk™.
"The pilot production program has advanced well ahead of our
expectations. At this rate, we will be facing some near term
decisions regarding the launching of commercial production. In
my opinion, we are now reaching major milestones every two to three
weeks. We are undergoing tremendous developmental changes,
which we believe will lead to substantial growth of our business
over the next few months," said Company founder and CEO, Kim
Thompson.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024